PETIC provides researchers and doctors with a far greater ability to detect malignant tissue and track the effects of drugs in incredible detail
As we enter our fifth year of operation, we've been looking back at some of the things the Wales Cancer Research Centre has made possible.
The first test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukaemia has been developed our staff at Cardiff University. The technology could guide doctors’ decisions on which drugs to give to patients.
Results from a trial looking into the effectiveness of combining two drugs (olaparib and abiraterone) for patients with a prostate cancer have recently been published in the Lancet Oncology.